Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 6 Uterine Cervical Neoplasms 5 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Fallopian Tube Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Myelodysplastic Syndromes 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Disease Progression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brenner Tumor 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Laparoscopy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Practice Guidelines as Topic × Gynecologic × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡